Supernus Pharma
SUPN----
Current ValuationThe current P/E ratio is -21.80, within the reasonable range, cheaper than 76.13% of the time in the past 5 years, and the industry ranks 205/256, the industry Median -1.15.
-21.8xP/E
$41.21Stock price
$-1.89Earnings per share
-21.8xP/E
Stock price$41.21Earnings per share$-1.89
Historical Valuation
P/E ratioTypical rangeMedian
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
0306090120
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.